Triple-negative breast cancer (TNBC) is an aggressive subtype of
breast cancer that tends to affect young women and has a high propensity to metastasize. No targeted treatments are available for this type of
breast cancer due to a lack of
estrogen or
progesterone receptors or overexpression of human
epidermal growth factor receptor type 2 overexpression. Currently, patients have no therapeutic options once standard of care is complete, indicating a need for safe and effective
therapies to slow or prevent the progression of TNBC to metastatic disease. Studies showed that isolated
polyphenols or
polyphenol-rich muscadine grape extracts
polyphenols inhibit the proliferation of various
cancer cells including
breast cancer. A proprietary muscadine grape extract (MGE) was administered to nude mice with human MDA-MB-231 TNBC atumors for 4 weeks to determine the effect of the extract on
tumor growth. MGE decreased
tumor volume in association with a reduction in the proliferative markers Ki67 and
cyclin D1. To determine the molecular mechanisms for the MGE-induced reduction in
tumor growth, mouse 4T1, MDA-MB-231, or human BT-549 TNBC cells were treated with MGE, and various signaling pathways were investigated. MGE reduced c-Met, differentially abrogated ERK/MAPK and AKT signaling, and decreased a downstream targets of ERK/MAPK and AKT pathways,
cyclin D1.
Cyclin D1 reduction was associated with
retinoblastoma activation and cell cycle arrest in MDA-MB-231 TNBC cells. MGE-regulated molecular signaling pathways were functionally associated with a dose-dependent reduction in cell proliferation. The pluripotency of MGE and high index of safety and tolerability suggest that the extract may serve as a therapeutic to reduce TNBC progression to metastatic disease.